Gsk Share Discussion Threads

[alphorn] 19/5/2022 12:53

Unilever xd today.

[patientcapital] 19/5/2022 12:50

At least we aren't in Unilever.

[tradermichael] 19/5/2022 12:24

- and a 4% drop in the DOW yesterday

[ifthecapfits] 19/5/2022 11:25

Hence the mini sell off i guess.

[patientcapital] 16/5/2022 16:24

Goes XD on Thursday.

[garycook] 16/5/2022 12:00

SocGen raises GlaxoSmithKline price target to 2,275 (2,115) pence - 'buy' Nice one.Would gladly take 2275p for my GSK.

[geckotheglorious] 16/5/2022 10:59

SocGen raises GlaxoSmithKline price target to 2,275 (2,115) pence - 'buy'

Looks a bit "rich" to me..

[tradermichael] 16/5/2022 08:17

USD 1.22 = £1

[watfordhornet] 13/5/2022 08:10

Looked like part of Hal's share incentive plan rather than a standard purchase

[netcurtains] 13/5/2022 07:36

Biggish director buy yesterday

[garycook] 13/5/2022 02:19

TM,Think your Broker got their facts wrong,by getting confused with the GSK name change GLAXOSMITHKLINE ORD GBP0.25
Event Type
Name Change
Description
Name Change

Old name: GlaxoSmithKline plc
New name: GSK plc
Expected effective date: Mid-May 2022

Please be informed that GlaxoSmithKline plc will change its name to GSK plc. The change is expected to become effective around the middle of May 2022.

No action is required from shareholders in relation to the name change.

[tradermichael] 12/5/2022 09:33

Yes, with xdiv next week and all ... ;0)

[charlie9038] 12/5/2022 09:30

Good time to add
gla

[waldron] 11/5/2022 12:56

27 July 2022 Announcement of Q2 2022 results
2 November 2022 Announcement of Q3 2022 results
1 February 2023 Announcement of Q4 2022 results

[jretlaw] 11/5/2022 12:53

Gsk is heavenly discounted at this price soon we will see a drastic race between funds to get in on the action 20 pounds herd we come im buying big time

[abdullla] 09/5/2022 14:40

Correct, thanks

[tradermichael] 09/5/2022 12:20

Further to my message ref. 29673, I have had an update from my broker who now states that the demerger will be complete by mid July 2022 (as most of us know).

[spyder] 07/5/2022 12:39

Good point TM, although .... this isn't really a float in the traditional sense.
I am a bit confused about how it will work exactly, but as I understanding ~1/3 of Haleon (the name is growing on me) belongs to Pfizer and ~2/3 to GSK and the shares will be apportioned accordingly and in GSK's case, 80% of the 2/3 will be passed on to (us) shareholders.
I presume there are no new shares being issued/funds raised, or perhaps there will be?
I know the Execs have been courting sovereign wealth funds etc, so I guess there may be an element of investment required at IPO, or is it more to do with ensuring a health demand for shares post IPO for those current shareholders who don't want to hold Haleon stock?

[tradermichael] 07/5/2022 08:32

The Nasdaq is now in a “bear market” after falling 22pc since the start of the year. April was its worst month since the 2008 financial crisis. The broader S&P 500 shed almost 4pc as the sell-off spread to other stocks, erasing about $1.3 trillion of market value.

TRADITIONALLY, THIS IS NOT A GOOD TIME TO FLOAT A NEW COMPANY!

[patientcapital] 07/5/2022 08:32

From GSK FAQs page on their website:"2. When is the demerger taking place?The demerger and listing of Haleon is expected to take place in July 2022."

[tradermichael] 07/5/2022 08:20

That's what I thought so I checked twice with AJ Bell and they gave out the same dates. I still believe July 2022 is correct. I have asked my broker to double check with Glaxo.

[abdullla] 06/5/2022 17:48

Not true and not possible,besides no body has received any correspondence from GSK.

[tradermichael] 06/5/2022 12:24

I had a note from my broker who has received information from GSK:

"The demerger is now expected to complete in mid-May 2022."
(Seems to conflict with earlier news from GSK elsewhere).